BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 29210304)

  • 1. Current management of refractory ascites in patients with cirrhosis.
    Zhao R; Lu J; Shi Y; Zhao H; Xu K; Sheng J
    J Int Med Res; 2018 Mar; 46(3):1138-1145. PubMed ID: 29210304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of ascites and hepatorenal syndrome.
    Piano S; Tonon M; Angeli P
    Hepatol Int; 2018 Feb; 12(Suppl 1):122-134. PubMed ID: 28836115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current status of treatment of refractory ascites in patients with liver cirrhosis].
    Shao J; Zhang L; Han GH; Fan DM
    Zhonghua Gan Zang Bing Za Zhi; 2016 Oct; 24(10):721-723. PubMed ID: 27938554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of refractory ascites.
    Wong F
    Clin Mol Hepatol; 2023 Jan; 29(1):16-32. PubMed ID: 35676862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
    Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of ascites in cirrhosis.
    Sandhu BS; Sanyal AJ
    Clin Liver Dis; 2005 Nov; 9(4):715-32, viii. PubMed ID: 16207572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An update on the pathogenesis and clinical management of cirrhosis with refractory ascites.
    Neong SF; Adebayo D; Wong F
    Expert Rev Gastroenterol Hepatol; 2019 Apr; 13(4):293-305. PubMed ID: 30791777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of refractory ascites.
    Singhal S; Baikati KK; Jabbour II; Anand S
    Am J Ther; 2012 Mar; 19(2):121-32. PubMed ID: 21192246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current approaches to the management of patients with cirrhotic ascites.
    Garbuzenko DV; Arefyev NO
    World J Gastroenterol; 2019 Jul; 25(28):3738-3752. PubMed ID: 31391769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current management and novel therapeutic strategies for refractory ascites and hepatorenal syndrome.
    Suzuki H; Stanley AJ
    QJM; 2001 Jun; 94(6):293-300. PubMed ID: 11391027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment for ascites in adults with decompensated liver cirrhosis: a network meta-analysis.
    Benmassaoud A; Freeman SC; Roccarina D; Plaz Torres MC; Sutton AJ; Cooper NJ; Iogna Prat L; Cowlin M; Milne EJ; Hawkins N; Davidson BR; Pavlov CS; Thorburn D; Tsochatzis E; Gurusamy KS
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD013123. PubMed ID: 31978257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transjugular intrahepatic portosystemic shunt in the management of ascites and hepatorenal syndrome.
    Senzolo M; Cholongitas E; Tibballs J; Burroughs A; Patch D
    Eur J Gastroenterol Hepatol; 2006 Nov; 18(11):1143-50. PubMed ID: 17033432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites.
    Rössle M; Ochs A; Gülberg V; Siegerstetter V; Holl J; Deibert P; Olschewski M; Reiser M; Gerbes AL
    N Engl J Med; 2000 Jun; 342(23):1701-7. PubMed ID: 10841872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis.
    Salerno F; Guevara M; Bernardi M; Moreau R; Wong F; Angeli P; Garcia-Tsao G; Lee SS
    Liver Int; 2010 Aug; 30(7):937-47. PubMed ID: 20492521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current concepts in the management of refractory cirrhotic ascites.
    Oguntona SA; Alebiosu CO
    Niger J Med; 2006; 15(3):197-202. PubMed ID: 17111742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data.
    Salerno F; Cammà C; Enea M; Rössle M; Wong F
    Gastroenterology; 2007 Sep; 133(3):825-34. PubMed ID: 17678653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Albumin May Prevent the Morbidity of Paracentesis-Induced Circulatory Dysfunction in Cirrhosis and Refractory Ascites: A Pilot Study.
    Tan HK; James PD; Wong F
    Dig Dis Sci; 2016 Oct; 61(10):3084-3092. PubMed ID: 27048451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of refractory ascites with an automated low-flow ascites pump in patients with cirrhosis.
    Stirnimann G; Berg T; Spahr L; Zeuzem S; McPherson S; Lammert F; Storni F; Banz V; Babatz J; Vargas V; Geier A; Stallmach A; Engelmann C; Trepte C; Capel J; De Gottardi A
    Aliment Pharmacol Ther; 2017 Nov; 46(10):981-991. PubMed ID: 28940225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refractory Ascites in Liver Cirrhosis.
    Adebayo D; Neong SF; Wong F
    Am J Gastroenterol; 2019 Jan; 114(1):40-47. PubMed ID: 29973706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TIPS for management of refractory ascites: response and survival are both unpredictable.
    Thuluvath PJ; Bal JS; Mitchell S; Lund G; Venbrux A
    Dig Dis Sci; 2003 Mar; 48(3):542-50. PubMed ID: 12757168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.